Landmark RxPONDER Trial Results

Publication in The New England Journal of Medicine Confirms that Tens of Thousands of Women with Node-positive, Early-stage Breast Cancer Can Avoid Chemotherapy with the Oncotype DX® Test

Exact Sciences' Response to COVID-19

A Letter from our CEO, Kevin Conroy

Making cancer care smarter.™